Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$6163b Graphic](https://lunarcrush.com/gi/w:26/t:$6163b.png) $6163b

Market volatility continues to dominate discussions as $6163b faces downward price pressure. Community members are actively engaging, seeking clarity amidst regulatory uncertainties.

### About $6163b
$6163b is a digital asset focused on decentralized finance and blockchain technology.  

### Insights [#](/topic/$6163b/insights)
- $6163b engagements hit 5833 which is XXX% higher than it's daily average.
- $6163b Creators hit a 52-Week high of X for the day
- $6163b Creators hit an all time of X for the day
- $6163b Mentions hit a 52-Week high of X for the day
- $6163b Mentions hit an all time of X for the day
- $6163b Engagements hit a 52-Week high of XXXXXX for the day
- $6163b Engagements hit an all time of XXXXXX for the day

### Engagements: XXXXX [#](/topic/$6163b/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$6163b/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$6163b/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXX  
**6 Months**: XXXXXX +5,187%  
**1 Year**: XXXXXX +9,440%  
**1-Year High**: XXXXXX on 2025-10-30  
**1-Year Low**: X on 2025-06-21  

| Social Network | X     |
| -------------- | -     |
| Engagements    | XXXXX |
  

  
  
### Mentions: X [#](/topic/$6163b/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$6163b/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$6163b/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**6 Months**: XX +25%  
**1 Year**: XX +1,600%  
**1-Year High**: X on 2025-11-01  
**1-Year Low**: X on 2024-12-04  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: X [#](/topic/$6163b/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$6163b/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$6163b/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $6163b in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**6 Months**: XX +25%  
**1 Year**: XX +1,600%  
**1-Year High**: X on 2025-11-01  
**1-Year Low**: X on 2024-12-04  

**Top assets mentioned**
In the posts about $6163b in the last XX hours

[Eli Lilly and Company (LLY)](/topic/eli-lilly)
[Eli Lilly and Company (LLY)](/topic/$lly)
[Novo-Nordisk (NVO)](/topic/$nvo)

**Top topics mentioned**
In the posts about $6163b in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [eli lilly](/topic/eli-lilly), [$lly](/topic/$lly), [$1760b](/topic/$1760b), [$1607b](/topic/$1607b), [$630b](/topic/$630b), [$635b](/topic/$635b), [eps](/topic/eps), [$652b](/topic/$652b), [$nvo](/topic/$nvo), [investment](/topic/investment), [money](/topic/money), [should be](/topic/should-be), [instead of](/topic/instead-of)

### Top Social Posts [#](/topic/$6163b/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"๐Ÿ”ฅ $LLY vs $NVO The Battle of the Obesity Kings $NVO is busy spending on acquisitions while $LLY just dropped another monster quarter ๐Ÿ’ช Eli Lilly Q3: ๐Ÿ’ฐ Revenue: $17.6B (vs $16.07B est) +54% YoY ๐Ÿ“ˆ EPS (Non-GAAP): $XXXX (vs $XXXX est) ๐Ÿงพ Gross Margin: XXXX% ๐Ÿš€ FY25 Guidance Raised: Revenue: $63.063.5B (vs $61.63B est) EPS: $23.00$23.70 (vs $XXXXX est) CEO David Ricks: Lilly delivered another strong quarter driven by demand for our incretin portfolio. Were expanding globally scaling capacity and building the future of metabolic health. $LLY is executing flawlessly scaling innovating and"  
[X Link](https://x.com/rahuls61193/status/1983956540957557052) [@rahuls61193](/creator/x/rahuls61193) 2025-10-30T17:57Z XXX followers, XXX engagements


"$LLY Eli Lilly Q325 Earnings Highlights ๐Ÿ”น Revenue: $17.60B (Est. $16.07B) ๐ŸŸข; UP +54% YoY ๐Ÿ”น EPS (Non-GAAP): $XXXX (Est. $5.89) ๐ŸŸข ๐Ÿ”น Gross Margin: XXXX% FY25 Guidance ๐Ÿ”น Revenue: $63.0B$63.5B (Est. $61.63B) ๐ŸŸข ๐Ÿ”น EPS (Non-GAAP): $23.00$23.70 (Est. $22.50) ๐ŸŸข ๐Ÿ”น Adj. Gross Margin: XX% ๐Ÿ”น Performance Margin: 45%46% (Non-GAAP) Segment ๐Ÿ”น Mounjaro: $6.52B; UP +109% YoY ๐Ÿ”น Zepbound: $3.59B; UP +185% YoY ๐Ÿ”น Verzenio: $1.47B; UP +7% YoY Other Metrics ๐Ÿ”น U.S. Revenue: $11.30B; UP +45% YoY ๐Ÿ”น OUS Revenue: $6.30B; UP +74% YoY CEO Commentary ๐Ÿ”ธ Lilly delivered another strong quarter with XX% revenue"  
[X Link](https://x.com/dominic_pirrone/status/1983905228639629703) [@dominic_pirrone](/creator/x/dominic_pirrone) 2025-10-30T14:34Z 5485 followers, XXX engagements


"$LLY Eli Lilly reports Q3 EPS $XXXX consensus $XXXX -- Q3 revenue $17.6B consensus $16.07B. -- Raises FY25 EPS view to $23.00-$23.70 from $21.75-$23.00 consensus $XXXXX. -- Raises FY25 revenue view to $63B-$63.5B from $60B-$62B consensus $61.63B"  
[X Link](https://x.com/CorleoneDon77/status/1983855901418385467) [@CorleoneDon77](/creator/x/CorleoneDon77) 2025-10-30T11:17Z 6447 followers, XXX engagements


"$NVO busy spending money on acquisitions. Value = unclear. Meanwhile $LLY with another great quarter. Maybe I should be investing in $LLY instead of $NVO Eli Lilly's Q3 numbers: - Revenue: $17.60B (Est. $16.07B) ๐ŸŸข+54% YoY - EPS (Non-GAAP): $XXXX (Est. $5.89) ๐ŸŸข - Gross Margin: 82.9%๐ŸŸข FY25 Guidance raised -- - Revenue: $63.0B$63.5B (Est. $61.63B) ๐ŸŸข - EPS (Non-GAAP): $23.00$23.70 (Est. $22.50) ๐ŸŸข $LLY CEO David Ricks: Lilly delivered another strong quarter with XX% revenue growth year-over-year driven by continued demand for our incretin portfolio". " We advanced Orforglipron through four"  
[X Link](https://x.com/TacticzH/status/1983854319381201002) [@TacticzH](/creator/x/TacticzH) 2025-10-30T11:11Z 29.5K followers, 28.8K engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$6163b Graphic $6163b

Market volatility continues to dominate discussions as $6163b faces downward price pressure. Community members are actively engaging, seeking clarity amidst regulatory uncertainties.

About $6163b

$6163b is a digital asset focused on decentralized finance and blockchain technology.

Insights #

  • $6163b engagements hit 5833 which is XXX% higher than it's daily average.
  • $6163b Creators hit a 52-Week high of X for the day
  • $6163b Creators hit an all time of X for the day
  • $6163b Mentions hit a 52-Week high of X for the day
  • $6163b Mentions hit an all time of X for the day
  • $6163b Engagements hit a 52-Week high of XXXXXX for the day
  • $6163b Engagements hit an all time of XXXXXX for the day

Engagements: XXXXX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
6 Months: XXXXXX +5,187%
1 Year: XXXXXX +9,440%
1-Year High: XXXXXX on 2025-10-30
1-Year Low: X on 2025-06-21

Social Network X
Engagements XXXXX

Mentions: X #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
6 Months: XX +25%
1 Year: XX +1,600%
1-Year High: X on 2025-11-01
1-Year Low: X on 2024-12-04

Social Network X
Mentions XX

Creators: X #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $6163b in the last XX hours which is no change from in the previous XX hours Daily Average: X
6 Months: XX +25%
1 Year: XX +1,600%
1-Year High: X on 2025-11-01
1-Year Low: X on 2024-12-04

Top assets mentioned In the posts about $6163b in the last XX hours

Eli Lilly and Company (LLY) Eli Lilly and Company (LLY) Novo-Nordisk (NVO)

Top topics mentioned In the posts about $6163b in the last XX hours

stocks healthcare, eli lilly, $lly, $1760b, $1607b, $630b, $635b, eps, $652b, $nvo, investment, money, should be, instead of

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"๐Ÿ”ฅ $LLY vs $NVO The Battle of the Obesity Kings $NVO is busy spending on acquisitions while $LLY just dropped another monster quarter ๐Ÿ’ช Eli Lilly Q3: ๐Ÿ’ฐ Revenue: $17.6B (vs $16.07B est) +54% YoY ๐Ÿ“ˆ EPS (Non-GAAP): $XXXX (vs $XXXX est) ๐Ÿงพ Gross Margin: XXXX% ๐Ÿš€ FY25 Guidance Raised: Revenue: $63.063.5B (vs $61.63B est) EPS: $23.00$23.70 (vs $XXXXX est) CEO David Ricks: Lilly delivered another strong quarter driven by demand for our incretin portfolio. Were expanding globally scaling capacity and building the future of metabolic health. $LLY is executing flawlessly scaling innovating and"
X Link @rahuls61193 2025-10-30T17:57Z XXX followers, XXX engagements

"$LLY Eli Lilly Q325 Earnings Highlights ๐Ÿ”น Revenue: $17.60B (Est. $16.07B) ๐ŸŸข; UP +54% YoY ๐Ÿ”น EPS (Non-GAAP): $XXXX (Est. $5.89) ๐ŸŸข ๐Ÿ”น Gross Margin: XXXX% FY25 Guidance ๐Ÿ”น Revenue: $63.0B$63.5B (Est. $61.63B) ๐ŸŸข ๐Ÿ”น EPS (Non-GAAP): $23.00$23.70 (Est. $22.50) ๐ŸŸข ๐Ÿ”น Adj. Gross Margin: XX% ๐Ÿ”น Performance Margin: 45%46% (Non-GAAP) Segment ๐Ÿ”น Mounjaro: $6.52B; UP +109% YoY ๐Ÿ”น Zepbound: $3.59B; UP +185% YoY ๐Ÿ”น Verzenio: $1.47B; UP +7% YoY Other Metrics ๐Ÿ”น U.S. Revenue: $11.30B; UP +45% YoY ๐Ÿ”น OUS Revenue: $6.30B; UP +74% YoY CEO Commentary ๐Ÿ”ธ Lilly delivered another strong quarter with XX% revenue"
X Link @dominic_pirrone 2025-10-30T14:34Z 5485 followers, XXX engagements

"$LLY Eli Lilly reports Q3 EPS $XXXX consensus $XXXX -- Q3 revenue $17.6B consensus $16.07B. -- Raises FY25 EPS view to $23.00-$23.70 from $21.75-$23.00 consensus $XXXXX. -- Raises FY25 revenue view to $63B-$63.5B from $60B-$62B consensus $61.63B"
X Link @CorleoneDon77 2025-10-30T11:17Z 6447 followers, XXX engagements

"$NVO busy spending money on acquisitions. Value = unclear. Meanwhile $LLY with another great quarter. Maybe I should be investing in $LLY instead of $NVO Eli Lilly's Q3 numbers: - Revenue: $17.60B (Est. $16.07B) ๐ŸŸข+54% YoY - EPS (Non-GAAP): $XXXX (Est. $5.89) ๐ŸŸข - Gross Margin: 82.9%๐ŸŸข FY25 Guidance raised -- - Revenue: $63.0B$63.5B (Est. $61.63B) ๐ŸŸข - EPS (Non-GAAP): $23.00$23.70 (Est. $22.50) ๐ŸŸข $LLY CEO David Ricks: Lilly delivered another strong quarter with XX% revenue growth year-over-year driven by continued demand for our incretin portfolio". " We advanced Orforglipron through four"
X Link @TacticzH 2025-10-30T11:11Z 29.5K followers, 28.8K engagements

$6163b
/topic/$6163b